Literature DB >> 16235187

Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy?

Yunn-Hwen Gan1.   

Abstract

Melioidosis is an infectious disease endemic in tropical and subtropical areas but is most often described in Southeast Asia and northern Australia. It has increasingly gained attention in the Western Hemisphere because of its potential use as a biological weapon. Progress in our understanding of the virulence mechanisms of Burkholderia pseudomallei, the causative agent, has provided clues to the pathogenesis of the disease. The bacterium can remain latent in the body for long periods of time and also possesses mechanisms to evade the host immune response. The complex spectrum of clinical manifestations resulting from infection could reflect the various outcomes after the host immune response encounters the bacteria. The use of appropriate animal models of susceptibility will likely shed light on what determines the development of an acute, chronic, or latent infection.

Entities:  

Mesh:

Year:  2005        PMID: 16235187     DOI: 10.1086/497382

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Near-atomic resolution analysis of BipD, a component of the type III secretion system of Burkholderia pseudomallei.

Authors:  M Pal; P T Erskine; R S Gill; S P Wood; J B Cooper
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-08-21

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 3.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Insights into horizontal acquisition patterns of dormancy and reactivation regulon genes in mycobacterial species using a partitioning-based framework.

Authors:  Varun Mehra; Tarini Shankar Ghosh; Sharmila S Mande
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

5.  pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells.

Authors:  Jennifer Chua; Jeffrey L Senft; Stephen J Lockett; Paul J Brett; Mary N Burtnick; David DeShazer; Arthur M Friedlander
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 6.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

7.  Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization.

Authors:  Soon-Keat Ooi; Tian-Yeh Lim; Song-Hua Lee; Sheila Nathan
Journal:  Virulence       Date:  2012-10-01       Impact factor: 5.882

Review 8.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

9.  Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials.

Authors:  Erin J van Schaik; Marina Tom; Donald E Woods
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

10.  Imported melioidosis, Israel, 2008.

Authors:  Avivit Cahn; Benjamin Koslowsky; Ran Nir-Paz; Violeta Temper; Nurit Hiller; Alla Karlinsky; Itzhak Gur; Carlos Hidalgo-Grass; Samuel N Heyman; Allon E Moses; Colin Block
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.